- Home
- FLNT vs BRNS Comparison
FLNT vs BRNS Comparison
Compare FLNT & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNT | BRNS |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FLNT | BRNS |
|---|---|---|
| Price | $2.07 | $0.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $4.00 |
| AVG Volume (30 Days) | 18.0K | ★ 144.0K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $212,352,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $1.50 | $0.64 |
| 52 Week High | $3.12 | $2.92 |
Technical Indicators
Market Signals| Indicator | FLNT | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 31.93 |
| Support Level | $1.72 | $0.72 |
| Resistance Level | $1.93 | $0.82 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 100.00 | 11.21 |
Price Performance
Historical ComparisonAbout FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.